Sign In
Buy MOS
$23.32
+0.0150 (+0.0644%)
At Close: Jun 03, 2026
Compared to Estimates, Mosaic (MOS) Q1 Earnings: A Look at Key Metrics
07:31pm, Wednesday, 01'st May 2024
While the top- and bottom-line numbers for Mosaic (MOS) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to
Mosaic (MOS) Q1 Earnings Beat Estimates
06:21pm, Wednesday, 01'st May 2024
Mosaic (MOS) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.60 per share. This compares to earnings of $1.14 per share a year ago.
Mosaic Announces First Quarter 2024 Results
04:35pm, Wednesday, 01'st May 2024
TAMPA, FL / ACCESSWIRE / May 1, 2024 / The Mosaic Company (NYSE:MOS) released its financial results for first quarter 2024. The company's earnings release and supplemental materials are available at h
Mosaic Enters Share Purchase and Subscription Agreement with Ma'aden
06:00am, Tuesday, 30'th Apr 2024
TAMPA, FL / ACCESSWIRE / April 30, 2024 / The Mosaic Company (NYSE:MOS) announced today that it has entered into an agreement with the Saudi Arabian Mining Company ("Ma'aden") under which Mosaic will
Mosaic (MOS) to Report Q1 Earnings: What's in the Offing?
10:50am, Monday, 29'th Apr 2024
Mosaic's (MOS) Q1 results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.
Countdown to Mosaic (MOS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 29'th Apr 2024
Besides Wall Street's top -and-bottom-line estimates for Mosaic (MOS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc.
07:00am, Monday, 29'th Apr 2024
- The clinical assets to be acquired include cancer and ocular disease programs, including regulatory and clinical packages and access to Oncotelic's AI platform for identifying immunotherapy combinat
Analysts Estimate Mosaic (MOS) to Report a Decline in Earnings: What to Look Out for
11:08am, Wednesday, 24'th Apr 2024
Mosaic (MOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mosaic Announces Dates For First Quarter 2024 Results And Conference Call
04:15pm, Wednesday, 10'th Apr 2024
TAMPA, FL / ACCESSWIRE / April 10, 2024 / The Mosaic Company (NYSE:MOS) plans to release first quarter 2024 earnings results on Wednesday, May 1, after close of trading on the New York Stock Exchange.
Mosaic (MOS) January and February Phosphates & Potash Volume Up
01:46pm, Monday, 01'st Apr 2024
Mosaic (MOS) discloses January and February 2024 revenues and sales volume, along with an update on the Riverview facility incident.
Mosaic Announces January and February 2024 Revenue and Sales Volumes, Update on Riverview Facility Incident
05:50pm, Wednesday, 27'th Mar 2024
TAMPA, FL / ACCESSWIRE / March 27, 2024 / The Mosaic Company (NYSE:MOS) announced its combined January and February 2024 sales volumes and revenue by business unit. Potash Jan/Feb 2024 Jan/Feb 2023 Sa
Mosaic Announces Quarterly Dividend of $0.21 Per Share
04:15pm, Thursday, 21'st Mar 2024
TAMPA, FL / ACCESSWIRE / March 21, 2024 / The Mosaic Company (NYSE:MOS) announced today that its Board of Directors declared a quarterly dividend of $0.21 per share on the Company's common stock. The
Mosaic (MOS) Declines More Than Market: Some Information for Investors
07:21pm, Thursday, 14'th Mar 2024
Mosaic (MOS) reachead $31.63 at the closing of the latest trading day, reflecting a -1% change compared to its last close.
Mosaic (MOS) Outperforms Broader Market: What You Need to Know
07:21pm, Thursday, 07'th Mar 2024
The latest trading day saw Mosaic (MOS) settling at $31.93, representing a +1.53% change from its previous close.
27 Upcoming Dividend Increases Including A Dividend King
12:15pm, Thursday, 29'th Feb 2024
A new list of 27 new dividend increases, including King Kimberly-Clark and three other champions.
